Peripheral iron levels in children with attention-deficit hyperactivity disorder: A systematic review and meta-analysis

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Tseng, Ping Tao ^a,b   Cheng, Yu Shian ^a   Yen, Cheng Fang ^c,d   Chen, Yen Wen ^e   Stubbs, Brendon ^f,g,h   Whiteley, Paul ⁱ   Carvalho, Andre F ^j   Li, Dian Jeng ^d,k   Chen, Tien Yu ^l   Yang, Wei Cheng ^k   Tang, Chia Hung ^m   Chu, Che Sheng ⁿ   Yang, Wei Chieh ^o   Liang, Hsin Yi ^p   Wu, Ching Kuan ^a   Lin, Pao Yen ^q,r  

^a Tsyr Huey (Loving) Mental Hospital   (Taiwan)

^b Winshine clinics in specialty of psychiatry   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e Prospect clinic for otorhinolaryngology and neurology   (Taiwan)

^f SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^g KING'S COLLEGE LONDON   (United Kingdom)

^h ANGLIA RUSKIN UNIVERSITY   (United Kingdom)

ⁱ ESPA Research   (United Kingdom)

^j FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^k Superintendent of Kaohsiung Kai Syuan Psychiatric Hospital   (Taiwan)

^l TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^m Tainan Hospital   (Taiwan)

ⁿ KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^o Da An Women and Children Hospital   (Taiwan)

^p CHANG GUNG UNIVERSITY   (Taiwan)

^q CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^r CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON;

ATTENTION DEFICIT DISORDER; BLOOD; CHILD; FACTUAL DATABASE; HUMAN; META ANALYSIS; METABOLISM; ODDS RATIO; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; DATABASES, FACTUAL; FERRITINS; HUMANS; IRON; ODDS RATIO; SEVERITY OF ILLNESS INDEX;

EID: 85040785075     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-19096-x     Document Type: Review

References (65)

1. Thomas, R., Sanders, S., Doust, J., Beller, E. &Glasziou, P. Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics 135, e994-1001, https://doi.org/10.1542/peds.2014-3482 (2015).
2. Thapar, A. &Cooper, M. Attention deficit hyperactivity disorder. Lancet 387, 1240-1250, https://doi.org/10.1016/S0140-6736(15)00238-X (2016).
3. Jameson, N. D. et al. Medical Comorbidity of Attention-Deficit/Hyperactivity Disorder in US Adolescents. J Child Neurol 31, 1282-1289, https://doi.org/10.1177/0883073816653782 (2016).
4. Faraone, S. V. et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57, 1313-1323, https://doi. org/10.1016/j.biopsych.2004.11.024 (2005).
5. Biederman, J. Attention-deficit/hyperactivity disorder: a selective overview. Biol Psychiatry 57, 1215-1220, https://doi.org/10.1016/j. biopsych.2004.10.020 (2005).
6. Polanska, K., Jurewicz, J. &Hanke, W. Exposure to environmental and lifestyle factors and attention-deficit / hyperactivity disorder in children-A review of epidemiological studies. Int J Occup Med Environ Health 25, 330-355, https://doi.org/10.2478/S13382-012-0048-0 (2012).
7. Konofal, E. et al. Effects of iron supplementation on attention deficit hyperactivity disorder in children. Pediatr Neurol 38, 20-26, https://doi.org/10.1016/j.pediatrneurol.2007.08.014 (2008).
8. Verlaet, A. A., Noriega, D. B., Hermans, N. &Savelkoul, H. F. Nutrition, immunological mechanisms and dietary immunomodulation in ADHD. Eur Child Adolesc Psychiatry 23, 519-529, https://doi.org/10.1007/s00787-014-0522-2 (2014).
9. Chen, M. H. et al. Association between psychiatric disorders and iron deficiency anemia among children and adolescents: a nationwide population-based study. BMC Psychiatry 13, 161, https://doi.org/10.1186/1471-244X-13-161 (2013).
10. Doom, J. R. &Georgieff, M. K. Striking while the iron is hot: Understanding the biological and neurodevelopmental effects of iron deficiency to optimize intervention in early childhood. Curr Pediatr Rep 2, 291-298, https://doi.org/10.1007/s40124-014-0058-4 (2014).
11. Bakoyiannis, I. et al. An explanation of the pathophysiology of adverse neurodevelopmental outcomes in iron deficiency. Rev Neurosci 26, 479-488, https://doi.org/10.1515/revneuro-2015-0012 (2015).
12. Hyacinthe, C. et al. Blood withdrawal affects iron store dynamics in primates with consequences on monoaminergic system function. Neuroscience 290, 621-635, https://doi.org/10.1016/j.neuroscience.2015.01.057 (2015).
13. Sever, Y., Ashkenazi, A., Tyano, S. &Weizman, A. Iron treatment in children with attention deficit hyperactivity disorder. A preliminary report. Neuropsychobiology 35, 178-180 (1997).
14. Scassellati, C., Bonvicini, C., Faraone, S. V. &Gennarelli, M. Biomarkers and attention-deficit/hyperactivity disorder: a systematic review and meta-analyses. J Am Acad Child Adolesc Psychiatry 51, 1003-1019 e1020, https://doi.org/10.1016/j.jaac.2012.08.015 (2012).
15. Tan, L. N., Wei, H. Y., Zhang, Y. D., Lu, A. L. &Li, Y. Relationship between serum ferritin levels and susceptibility to attention deficit hyperactivity disorder in children: a Meta analysis. Zhongguo Dang Dai Er Ke Za Zhi 13, 722-724 (2011).
16. Wang, Y., Huang, L., Zhang, L., Qu, Y. &Mu, D. Iron Status in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis. PLoS One 12, e0169145, https://doi.org/10.1371/journal.pone.0169145 (2017).
17. Finazzi, D. &Arosio, P. Biology of ferritin in mammals: an update on iron storage, oxidative damage and neurodegeneration. Arch Toxicol 88, 1787-1802, https://doi.org/10.1007/s00204-014-1329-0 (2014).
18. Sharma, A. &Couture, J. A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD). Ann Pharmacother 48, 209-225, https://doi.org/10.1177/1060028013510699 (2014).
19. Konofal, E., Cortese, S., Lecendreux, M., Arnulf, I. &Mouren, M. C. Effectiveness of iron supplementation in a young child with attention-deficit/hyperactivity disorder. Pediatrics 116, e732-734, https://doi.org/10.1542/peds.2005-0715 (2005).
20. Al-Ayadhi, L. Y. Heavy metals and trace elements in hair samples of autistic children in central Saudi Arabia. Neurosciences (Riyadh) 10, 213-218 (2005).
21. Antalis, C. J. et al. Omega-3 fatty acid status in attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids 75, 299-308, https://doi.org/10.1016/j.plefa.2006.07.004 (2006).
22. Dura-Trave, T. &Gallinas-Victoriano, F. Caloric and nutrient intake in children with attention deficit hyperactivity disorder treated with extended-release methylphenidate: analysis of a cross-sectional nutrition survey. JRSM Open 5, 2042533313517690, https://doi. org/10.1177/2042533313517690 (2014).
23. Mahmoud, M. M., El-Mazary, A. A., Maher, R. M. &Saber, M. M. Zinc, ferritin, magnesium and copper in a group of Egyptian children with attention deficit hyperactivity disorder. Ital J Pediatr 37, 60, https://doi.org/10.1186/1824-7288-37-60 (2011).
24. Abou-Khadra, M. K., Amin, O. R., Shaker, O. G. &Rabah, T. M. Parent-reported sleep problems, symptom ratings, and serum ferritin levels in children with attention-deficit/hyperactivity disorder: a case control study. BMC Pediatr 13, 217, https://doi. org/10.1186/1471-2431-13-217 (2013).
25. Bala, K. A. et al. Hormone disorder and vitamin deficiency in attention deficit hyperactivity disorder (ADHD) and autism spectrum disorders (ASDs). J Pediatr Endocrinol Metab 29, 1077-1082, https://doi.org/10.1515/jpem-2015-0473 (2016).
26. Bener, A., Kamal, M., Bener, H. &Bhugra, D. Higher prevalence of iron deficiency as strong predictor of attention deficit hyperactivity disorder in children. Ann Med Health Sci Res 4, S291-297, https://doi.org/10.4103/2141-9248.141974 (2014).
27. Chen, J. R., Hsu, S. F., Hsu, C. D., Hwang, L. H. &Yang, S. C. Dietary patterns and blood fatty acid composition in children with attention-deficit hyperactivity disorder in Taiwan. J Nutr Biochem 15, 467-472, https://doi.org/10.1016/j.jnutbio.2004.01.008 (2004).
28. Cortese, S. et al. Brain iron levels in attention-deficit/hyperactivity disorder: a pilot MRI study. World J Biol Psychiatry 13, 223-231, https://doi.org/10.3109/15622975.2011.570376 (2012).
29. Donfrancesco, R. et al. Iron and ADHD: time to move beyond serum ferritin levels. J Atten Disord 17, 347-357, https://doi. org/10.1177/1087054711430712 (2013).
30. Doom, J. R., Georgieff, M. K. &Gunnar, M. R. Institutional care and iron deficiency increase ADHD symptomology and lower IQ 2.5-5 years post-adoption. Dev Sci 18, 484-494, https://doi.org/10.1111/desc.12223 (2015).
31. Fuglestad, A. J. et al. Iron deficiency after arrival is associated with general cognitive and behavioral impairment in postinstitutionalized children adopted from Eastern Europe. Matern Child Health J 17, 1080-1087, https://doi.org/10.1007/s10995-012-1090-z (2013).
32. Juneja, M., Jain, R., Singh, V. &Mallika, V. Iron deficiency in Indian children with attention deficit hyperactivity disorder. Indian Pediatr 47, 955-958 (2010).
33. Konofal, E. et al. Impact of restless legs syndrome and iron deficiency on attention-deficit/hyperactivity disorder in children. Sleep Med 8, 711-715, https://doi.org/10.1016/j.sleep.2007.04.022 (2007).
34. Konofal, E., Lecendreux, M., Arnulf, I. &Mouren, M. C. Iron deficiency in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 158, 1113-1115, https://doi.org/10.1001/archpedi.158.12.1113 (2004).
35. Kwon, H. J. et al. Transferrin in korean children with attention deficit hyperactivity disorder. Psychiatry Investig 8, 366-371, https:// doi.org/10.4306/pi.2011.8.4.366 (2011).
36. Menegassi, M. et al. Food intake and serum levels of iron in children and adolescents with attention-deficit/hyperactivity disorder. Rev Bras Psiquiatr 32, 132-138 (2010).
37. Millichap, J. G., Yee, M. M. &Davidson, S. I. Serum ferritin in children with attention-deficit hyperactivity disorder. Pediatr Neurol 34, 200-203, https://doi.org/10.1016/j.pediatrneurol.2005.09.001 (2006).
38. Percinel, I., Yazici, K. U. &Ustundag, B. Iron Deficiency Parameters in Children and Adolescents with Attention-Deficit/ Hyperactivity Disorder. Child Psychiatry Hum Dev 47, 259-269, https://doi.org/10.1007/s10578-015-0562-y (2016).
39. Romanos, M. et al. No cross-sectional and longitudinal association of ferritin and symptoms of attention-deficit-/hyperactivity disorder in a large population-based sample of children: results from the GINIplus and LISAplus studies. Atten Defic Hyperact Disord 5, 313-320, https://doi.org/10.1007/s12402-013-0108-8 (2013).
40. Stang, A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in metaanalyses. Eur J Epidemiol 25, 603-605, https://doi.org/10.1007/s10654-010-9491-z (2010).
41. Juni, P., Witschi, A., Bloch, R. &Egger, M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 282, 1054-1060 (1999).
42. Lane, D. J. &Richardson, D. R. The active role of vitamin C in mammalian iron metabolism: much more than just enhanced iron absorption! Free Radic Biol Med 75, 69-83, https://doi.org/10.1016/j.freeradbiomed.2014.07.007 (2014).
43. Beard, J. L., Chen, Q., Connor, J. &Jones, B. C. Altered monamine metabolism in caudate-putamen of iron-deficient rats. Pharmacol Biochem Behav 48, 621-624 (1994).
44. Burhans, M. S. et al. Iron deficiency: differential effects on monoamine transporters. Nutr Neurosci 8, 31-38, https://doi. org/10.1080/10284150500047070 (2005).
45. Daubner, S. C., Le, T. &Wang, S. Tyrosine hydroxylase and regulation of dopamine synthesis. Arch Biochem Biophys 508, 1-12, https://doi.org/10.1016/j.abb.2010.12.017 (2011).
46. Earley, C. J. et al. Altered brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis-Ekbom Disease). Sleep Med 15, 1288-1301, https://doi.org/10.1016/j.sleep.2014.05.009 (2014).
47. Youdim, M. B., Ben-Shachar, D., Ashkenazi, R. &Yehuda, S. Brain iron and dopamine receptor function. Adv Biochem Psychopharmacol 37, 309-321 (1983).
48. Ranganath, A. &Jacob, S. N. Doping the Mind: Dopaminergic Modulation of Prefrontal Cortical Cognition. Neuroscientist 22, 593-603, https://doi.org/10.1177/1073858415602850 (2016).
49. Ghorayeb, I., Gamas, A., Mazurie, Z. &Mayo, W. Attention-Deficit Hyperactivity and Obsessive-Compulsive Symptoms in Adult Patients With Primary Restless Legs Syndrome: Different Phenotypes of the Same Disease? Behav Sleep Med 1-8, https://doi.org/10 .1080/15402002.2017.1326919 (2017).
50. Kul, M. et al. Evaluation of Oxidative Metabolism in Child and Adolescent Patients with Attention Deficit Hyperactivity Disorder. Psychiatry Investig 12, 361-366, https://doi.org/10.4306/pi.2015.12.3.361 (2015).
51. Adisetiyo, V. et al. Multimodal MR imaging of brain iron in attention deficit hyperactivity disorder: a noninvasive biomarker that responds to psychostimulant treatment? Radiology 272, 524-532, https://doi.org/10.1148/radiol.14140047 (2014).
52. D'Amato, T. J. Is iron deficiency causative of attention-deficit/hyperactivity disorder? Arch Pediatr Adolesc Med 159, 788; author reply 788, https://doi.org/10.1001/archpedi.159.8.788-A (2005).
53. Zacharski, L. R., Ornstein, D. L., Woloshin, S. &Schwartz, L. M. Association of age, sex, and race with body iron stores in adults: analysis of NHANES III data. Am Heart J 140, 98-104, https://doi.org/10.1067/mhj.2000.106646 (2000).
54. Stroup, D. F. et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283, 2008-2012 (2000).
55. Adisetiyo, V. &Helpern, J. A. Brain iron: a promising noninvasive biomarker of attention-deficit/hyperactivity disorder that warrants further investigation. Biomark Med 9, 403-406, https://doi.org/10.2217/bmm.15.9 (2015).
56. Yui, K., Imataka, G., Nakamura, H., Ohara, N. &Naito, Y. Eicosanoids Derived From Arachidonic Acid and Their Family Prostaglandins and Cyclooxygenase in Psychiatric Disorders. Curr Neuropharmacol 13, 776-785 (2015).
57. Higgins, J. P., Thompson, S. G. &Spiegelhalter, D. J. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc 172, 137-159, https://doi.org/10.1111/j.1467-985X.2008.00552.x (2009).
58. Borenstein, M., Hedges, L. V., Higgins, J. P. &Rothstein, H. R. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 1, 97-111, https://doi.org/10.1002/jrsm.12 (2010).
59. Higgins, J. P. &Thompson, S. G. Quantifying heterogeneity in a meta-analysis. Stat Med 21, 1539-1558, https://doi.org/10.1002/ sim.1186 (2002).
60. Borenstein, M., Higgins, J. P., Hedges, L. V. &Rothstein, H. R. Basics of meta-analysis: I2 is not an absolute measure of heterogeneity. Res Synth Methods 8, 5-18, https://doi.org/10.1002/jrsm.1230 (2017).
61. Higgins, J. P. &Green, S. In Cochrane Handbook for Systematic Reviews of Interventions (eds Higgins, J. P. &Green, S.). (Cochrane Library, 2011).
62. Egger, M., Davey Smith, G., Schneider, M. &Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629-634 (1997).
63. Duval, S. &Tweedie, R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in metaanalysis. Biometrics 56, 455-463 (2000).
64. Tobias, A. Assessing the influence of a single study in meta-analysis. STATA technical bulletin 47, 15-17 (1999).
65. Davey, J., Turner, R. M., Clarke, M. J. &Higgins, J. P. Characteristics of meta-analyses and their component studies in the Cochrane Database of Systematic Reviews: a cross-sectional, descriptive analysis. BMC Med Res Methodol 11, 160, https://doi. org/10.1186/1471-2288-11-160 (2011).